Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Howland

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|October 27, 2011
Universal nanopatternable interfacial bondingYuzhe Ding, Shaun Garland, Michael Howland, et al.
One Health (Amsterdam, Netherlands)|January 24, 2023
Is there a higher risk of exposure to <i>Coxiella burnetii</i> for pre-clinical veterinary students?Anne Conan, Christa A Gallagher, Nicole Erskine, et al.
Future Oncology (London, England)|December 15, 2025
Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trialRichard M Zuniga, Ari VanderWalde, Lee S Schwartzberg, et al.
Future Oncology (London, England)|June 26, 2020
Infigratinib in patients with advanced cholangiocarcinoma with <i>FGFR2</i> gene fusions/translocations: the PROOF 301 trialShalini Makawita, Ghassan K Abou-Alfa, Sameek Roychowdhury, et al.
Targeted Oncology|March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid TumorsCathy Eng, Nehal J Lakhani, Philip A Philip, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advanced Materials (Deerfield Beach, Fla.)|October 27, 2011
Universal nanopatternable interfacial bondingYuzhe Ding, Shaun Garland, Michael Howland, et al.
One Health (Amsterdam, Netherlands)|January 24, 2023
Is there a higher risk of exposure to <i>Coxiella burnetii</i> for pre-clinical veterinary students?Anne Conan, Christa A Gallagher, Nicole Erskine, et al.
Future Oncology (London, England)|December 15, 2025
Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trialRichard M Zuniga, Ari VanderWalde, Lee S Schwartzberg, et al.
Future Oncology (London, England)|June 26, 2020
Infigratinib in patients with advanced cholangiocarcinoma with <i>FGFR2</i> gene fusions/translocations: the PROOF 301 trialShalini Makawita, Ghassan K Abou-Alfa, Sameek Roychowdhury, et al.
Targeted Oncology|March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid TumorsCathy Eng, Nehal J Lakhani, Philip A Philip, et al.
Pageof 1